TGX-007

Trogenix ltd · Phase 1 active Small molecule

At a glance

Generic name	TGX-007
Sponsor	Trogenix ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TGX-007 CI brief — competitive landscape report
TGX-007 updates RSS · CI watch RSS
Trogenix ltd portfolio CI